Suntaek Hong

Prof. Suntaek Hong

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2017 in Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
SHSuntaek Hong
Suntaek Hong
Suntaek Hong. J Cancer Prev 2017;22:203-10. https://doi.org/10.15430/JCP.2017.22.4.203

30 June 2017 in Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
HTHuyen Trang Ha Thi
Huyen Trang Ha Thi
SHSuntaek Hong
Suntaek Hong
Huyen Trang Ha Thi, and Suntaek Hong. J Cancer Prev 2017;22:62-73. https://doi.org/10.15430/JCP.2017.22.2.62

24 October 2011 in Oncogene
Verified
Journal Article
Open access
PDF file
SASung Min Ahn
Sung Min Ahn
JCJi-Young Cha
Ji-Young Cha
JKJ Kim
J Kim
DKD Kim
D Kim
HTH T H Trang
H T H Trang
SHSuntaek Hong
Suntaek Hong
To identify potential microRNA (miRNA) links between Smad3, a mediator of TGF-β (transforming growth factor-β) signaling, and E-cadherin, we characterized the miRNA profiles of two gastric cancer cell lines: SNU484-LPCX, which does not express Smad3, and SNU484-Smad3, in which Smad3 is overexpressed. We found that among differentially expressed miRNAs, miR-200 family members are overexpressed in SNU484-Smad3 cells. Subsequent studies, including analysis of the effects of silencing Smad3 in SNU484-Smad3 cells and a luciferase reporter assay, revealed that Smad3 directly binds to a Smad-binding element located in the promoter region of miR-200b/a, where it functions as a transcriptional activator. TGF-β did not affect the regulatory role of Smad3 in transcription of miR-200 and expression of epithelial–mesenchymal transition markers. We conclude that Smad3 regulates, at the transcriptional level, miR-200 family members, which themselves regulate ZEB1 and ZEB2, known transcriptional repressors of E-cadherin, at the posttranscriptional level in a TGF-β-independent manner. This represents a novel link between Smad3 and posttranscriptional regulation by miRNAs in epithelial–mesenchymal transition in gastric cancer cells.

1 July 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HKHye-Youn Kim
Hye-Youn Kim
YKYoung-Mi Kim
Young-Mi Kim
SHSuntaek Hong
Suntaek Hong
Colorectal cancer (CRC) is the third most common cancer, and is associated with a high percentage of cancer-related death globally. Furthermore, the success rate of therapeutic treatment for CRC patients mainly depends on the status of metastasis. Therefore, novel drugs or therapeutic techniques should be discovered for the treatment of metastatic CRC. In this study, we selected Astaxanthin (AXT), one of the most common carotenoids, as a novel metastasis inhibitor through high-throughput drug screening based on invadopodia staining, and confirmed the anti-migratory and anti-invasive activity of AXT. We demonstrated that AXT increases miR-29a-3p and miR-200a expression, and thereby suppresses the expression of MMP2 and ZEB1, respectively. As a result, AXT represses the epithelial-mesenchymal transition (EMT) of CRC cells. Through the mechanistic study, we identified that AXT shows anti-metastatic activity through the transcriptional repression of MYC transcription factor. Finally, we also confirmed that AXT suppresses the in vivo metastatic capacity of colon cancer cell using mouse model. Collectively, we uncovered the novel function of AXT in the inhibition of EMT and invadopodia formation, implicating the novel therapeutic potential for AXT in metastatic CRC patients.


8 May 2021 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
HKHye-Youn Kim
Hye-Youn Kim
YKYoung-Mi Kim
Young-Mi Kim
SHSuntaek Hong
Suntaek Hong
DNAJB9, a member of the heat shock protein 40 family, acts as a multifunctional player involved in the maintenance of their client proteins and cellular homeostasis. However, the mechanistic action of DNAJB9 in human malignancies is yet to be fully understood. In this study, we found that ectopic restoration of DNAJB9 inhibits the migration, invasion, in vivo metastasis, and lung colonization of triple-negative breast cancer (TNBC) cells. Mechanistically, DNAJB9 stabilizes FBXO45 protein by suppressing self-ubiquitination and reduces the abundance of ZEB1 by Lys48-linked polyubiquitination to inhibit the epithelial–mesenchymal transition (EMT) and metastasis. Clinically, the reduction of DNAJB9 expression, concomitant with decreased FBXO45 abundance in breast cancer tissues, correlates with poorer clinical outcomes of patients with breast cancer. Taken together, our results provide a novel insight into the metastasis of TNBC and define a promising therapeutic strategy for cancers with overactive ZEB1 by regulating the DNAJB9–FBXO45 signaling axis.